More than 90 million Americans need it each year—but there may be sites of the body, and patients, most vulnerable to the ...

"Go and see your doctor if you've got anything that you're concerned about – that's what a [doctor] is for," Brian Gemmell ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Researchers have developed a first-of-its-kind wearable device capable of continuously scanning the lungs and heart of hospital patients while they rest in bed—offering a revolutionary alternative to ...

Lung cancer remains one of the leading cancer killers in the world, even with new advancements in the medical field.

Diagnosis is usually delayed due to low uptake of screening programs and access to accurate and safe biopsy techniques. Lung biopsies can be tricky, given their structure and function, but advanced ...

If you are a current or former smoker, you may qualify for a 10-minute lifesaving screening In 2023, one in eight adults was a smoker in Rockland County. Lung cancer is the most common cancer in ...

Johnson & Johnson MedTech partners with Qure.ai for early lung cancer detection in India, improving access to timely ...

This initiative is part of Project BreatheEZ, a broader strategic collaboration between Qure.ai and Johnson & Johnson MedTech, and designed to establish AI-led Incidental Pulmonary Nodule (IPN) ...

Raymond Osarogiagbon, MD, discusses innovative strategies for improving lung cancer screening, including artificial intelligence (AI) tools and simplified eligibility criteria.

The study highlights that while the risk from a single scan is low, it is not zero. Children and teenagers are at higher risk ...